Lauric acid attenuates 14-day DDC-induced cholangiopathy in association with reduced NF-κB-CCL2 signaling and restored LRH-1-regulated gene expression
World Journal of Gastroenterology · 2027-01-14 · 33 (2)
DOI: 10.3748/wjg.125044 ↗Abstract
BACKGROUND Chronic inflammatory cholangiopathies involve bile duct injury, biochemical cholestasis, hepatocellular injury, immune cell recruitment, oxidative stress, and fibrogenic remodeling. We previously demonstrated that 20% dietary lauric acid (LA) protected against early 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-induced cholangiopathy (proof of concept) by activating liver receptor homolog-1 (LRH-1). AIM To determine whether concurrent low-dose 5% dietary LA supplementation attenuates 14-day DDC-induced cholangiopathy and to characterize the associated inflammatory and metabolic responses. METHODS Eight-week-old male C57BL/6J mice were fed for 14 days with either Chow, 0.1% DDC, 5% LA, or a 0.1% DDC diet supplemented with 5% LA. RESULTS DDC feeding induced severe hepatocellular and cholestatic liver injury, macrophage infiltration, ductular reaction, oxidative stress, hepatocyte senescence, and fibrogenic remodeling. LA supplementation significantly reduced DDC-induced elevations of serum aminotransferases, bilirubin, and total bile acids, and decreased hepatic F4/80-positive macrophage infiltration and Picrosirius red collagen staining. LA supplementation restored hepatic expression of LRH-1-dependent genes involved in bile acid homeostasis, which DDC suppressed. Furthermore, DDC suppressed ileal farnesoid X receptor-fibroblast growth factor 15 signaling, which LA normalized, and LA attenuated DDC-induced hepatic oxidative and nitrosative stress and improved the expression of mitochondrial fatty acid metabolism genes. LA was associated with suppressed hepatic fibrosis markers and promoted anti-inflammatory macrophage genetic signatures. Notably, DDC activated nuclear factor-kappa B binding to the C-C motif chemokine ligand 2 promoter and repressed LRH-1 transcription, which were reversed by LA supplementation. CONCLUSION Dietary LA attenuated chronic DDC cholangiopathy which was associated with reduced nuclear factor-kappa B-dependent inflammatory signaling and restoring LRH-1-mediated bile acid homeostasis. This positions LA as a potential therapeutic strategy for inflammatory cholangiopathy.
EUVIMED